Calmark Sweden Past Earnings Performance

Past criteria checks 0/6

Calmark Sweden's earnings have been declining at an average annual rate of -39.3%, while the Medical Equipment industry saw earnings growing at 4.3% annually. Revenues have been declining at an average rate of 31.7% per year.

Key information

-39.3%

Earnings growth rate

-17.9%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate-31.7%
Return on equity-54.1%
Net Margin-16,348.5%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Calmark Sweden makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:9C7 Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 230-22170
30 Sep 230-32200
30 Jun 230-44220
31 Mar 230-47240
31 Dec 220-48250
30 Sep 221-41250
30 Jun 223-29250
31 Mar 226-27270
31 Dec 219-22280
30 Sep 2110-18280
30 Jun 2111-15250
31 Mar 219-12210
31 Dec 2010-11200
30 Sep 2017-9260
30 Jun 2015-9240
31 Mar 2012-9210
31 Dec 1911-8190
30 Sep 196-7130
30 Jun 195-7120
31 Mar 197-6130
31 Dec 185-5100
30 Sep 183-470
30 Jun 183-460
31 Mar 182-350
31 Dec 172-350
31 Dec 160-220

Quality Earnings: 9C7 is currently unprofitable.

Growing Profit Margin: 9C7 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 9C7 is unprofitable, and losses have increased over the past 5 years at a rate of 39.3% per year.

Accelerating Growth: Unable to compare 9C7's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 9C7 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-9.8%).


Return on Equity

High ROE: 9C7 has a negative Return on Equity (-54.09%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies